NEURON BIO, S.A. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
-.--% | -.--% |
| 2017 | Neuron BioLabs, S.L. cancelled the acquisition of diagnostics operations, R&D services and patents of Alzheimer's disease from Neuron Bio, SA. | CI |
| 2017 | Neol Biosolutions Seeks Investors | CI |
Chart: Technical Analysis
- Stock Market
- Equities
- NEU Stock
- Charts Neuron Bio, S.A.
